Improved homology modeling of the human & rat EP4 prostanoid receptors
Autor: | Stephen Douglas Barrett, Chi S. Ho, A.J. Stein, M.C. Holt, M. Ines Morano |
---|---|
Rok vydání: | 2019 |
Předmět: |
Models
Molecular Rhodopsin Prostaglandin E2 Prostaglandin E2 receptor EP4 Receptor Heart failure Computational biology Ligands Dinoprostone Radioligand Animals Humans Amino Acid Sequence Homology modeling lcsh:QH573-671 Receptor Molecular Biology G protein-coupled receptor Bone healing Homology model lcsh:Cytology EP4 Chemistry Decapodiformes Prostaglandin E2 receptor subtype 4 Cell Biology Rats Molecular Docking Simulation Structural Homology Protein Docking (molecular) lipids (amino acids peptides and proteins) PGE2 Structure-based drug design Threading (protein sequence) Receptors Prostaglandin E EP4 Subtype Research Article |
Zdroj: | BMC Molecular and Cell Biology BMC Molecular and Cell Biology, Vol 20, Iss 1, Pp 1-14 (2019) |
ISSN: | 2661-8850 |
Popis: | Background The EP4 prostanoid receptor is one of four GPCRs that mediate the diverse actions of prostaglandin E2 (PGE2). Novel selective EP4 receptor agonists would assist to further elucidate receptor sub-type function and promote development of therapeutics for bone healing, heart failure, and other receptor associated conditions. The rat EP4 (rEP4) receptor has been used as a surrogate for the human EP4 (hEP4) receptor in multiple SAR studies. To better understand the validity of this traditional approach, homology models were generated by threading for both receptors using the RaptorX server. These models were fit to an implicit membrane using the PPM server and OPM database with refinement of intra and extracellular loops by Prime (Schrödinger). To understand the interaction between the receptors and known agonists, induced-fit docking experiments were performed using Glide and Prime (Schrödinger), with both endogenous agonists and receptor sub-type selective, small-molecule agonists. The docking scores and observed interactions were compared with radioligand displacement experiments and receptor (rat & human) activation assays monitoring cAMP. Results Rank-ordering of in silico compound docking scores aligned well with in vitro activity assay EC50 and radioligand binding Ki. We observed variations between rat and human EP4 binding pockets that have implications in future small-molecule receptor-modulator design and SAR, specifically a S103G mutation within the rEP4 receptor. Additionally, these models helped identify key interactions between the EP4 receptor and ligands including PGE2 and several known sub-type selective agonists while serving as a marked improvement over the previously reported models. Conclusions This work has generated a set of novel homology models of the rEP4 and hEP4 receptors. The homology models provide an improvement upon the previously reported model, largely due to improved solvation. The hEP4 docking scores correlates best with the cAMP activation data, where both data sets rank order Rivenprost>CAY10684 > PGE1 ≈ PGE2 > 11-deoxy-PGE1 ≈ 11-dexoy-PGE2 > 8-aza-11-deoxy-PGE1. This rank-ordering matches closely with the rEP4 receptor as well. Species-specific differences were noted for the weak agonists Sulprostone and Misoprostol, which appear to dock more readily within human receptor versus rat receptor. Electronic supplementary material The online version of this article (10.1186/s12860-019-0212-5) contains supplementary material, which is available to authorized users. |
Databáze: | OpenAIRE |
Externí odkaz: |